http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201813661-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7597b17b6f183abffacdf29b620726b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2016-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a009e32214b59ac5813026d94d411c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52e865f2144287e5476873bfc5b2e62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6891799ff47484a5cc4dba39355b92a8 |
| publicationDate | 2018-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201813661-A |
| titleOfInvention | Use of a multi-peptide composition for the preparation of an anti-inflammatory drug |
| abstract | The invention provides a use of a polypeptide composition for preparing an anti-inflammatory medicine, wherein the pharmaceutical product comprises an effective dose of a polypeptide composition and a pharmaceutically acceptable carrier thereof; wherein the polypeptide composition Contains interleukin-4 (IL-4), IL-6, IL-10, angiopoietin (ANG), IL-1β, IL-16, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF -α), granulocyte-macrophage community stimulating factor (GM-CSF), intercellular adhesion molecule-1 (ICAM-1), IL-12p70, hepatocyte growth factor (HGF), basic fibroblast growth Factor (bFGF) and fibroblast growth factor-7 (FGF-7). The use of the polypeptide composition of the present invention achieves the ability to inhibit inflammatory reactions caused by alopecia dermatitis, rose spots, and eczema. |
| priorityDate | 2016-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 274.